Ensho Therapeutics, Inc. research brief

CIK 2032849 Copy CIK

Generated Nov. 2, 2026, 12:08 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Woodcliff Lake NJ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Oct. 15, 2026 · D · 0002032849-26-000002 · Source evidence

  Reported offering amount: 15604179 USD. Reported amount sold: 7281948 USD.

• Feb. 9, 2026 · D · 0002032849-26-000001 · Source evidence

  Reported offering amount: 20000000 USD. Reported amount sold: 0 USD.

• Sept. 12, 2025 · D · 0002032849-25-000003 · Source evidence

  Reported offering amount: 22500000 USD. Reported amount sold: 22500000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Ensho Therapeutics, Inc. research brief,” CIK 2032849, retrieved Nov. 2, 2026, 12:08 p.m.. Cite the specific accessions used. No amounts have been summed.